icd 10 code for squamous cell carcinoma in situ

By clicking below on the button labeled "I accept", you hereby acknowledge that you have read, understood and agreed to all terms and conditions set forth in this agreement. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials. I hope this helps you. FAQ icd 10 code for basal cell carcinoma of nose What is the ICD 10 for basal cell carcinoma of skin? Lady T:cool: [QUOTE="jh1991, post: 469112, member: 237375"] THE UNITED STATES _, C68. Carcinoma In Situ ICD-10-CM Alphabetical Index The ICD-10-CM Alphabetical Index is designed to allow medical coders to look up various medical terms and connect them with the appropriate ICD codes. Self-Administered Drug (SAD) Exclusion List articles list the CPT/HCPCS codes that are excluded from coverage under this category. Verrucous carcinoma is a type of squamous cell carcinoma (SCC) that can develop in your gums and cheeks the oral cavity as well as your genitals and feet. If malignant, any secondary (metastatic) sites should also be . Privacy Policy | Terms & Conditions | Contact Us. All rights reserved. The medical record/ progress note should indicate the removal of a malignant or an ambiguous, but moderate to high suspicion lesion with a corresponding pathology report.The size and location of the lesion should be documented in the operative report. End User License Agreement: malignant, in situ, benign, etc. accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the Sign up to get the latest information about your choice of CMS topics in your inbox. thank you i will Hi complete information, CMS does not guarantee that there are no errors in the information displayed on this web site. C44.311 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. These rules can be found i n the front of the ICD-O-3 code book. C44.12: Squamous cell carcinoma of skin of eyelid, including canthus. The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient. The American Hospital Association ("the AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. Since the morphology of the lesions can mimic that of other cutaneous disorders, Bowen's disease is often not recognized initially. . All Rights Reserved (or such other date of publication of CPT). The term "in situ" added on the end tells us that this is a surface form of skin cancer. A Draft article will eventually be replaced by a Billing and Coding article once the Proposed LCD is released to a final LCD. You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. Squamous cell carcinoma in situ, skin of face ICD-10-CM D04.30 is grouped within Diagnostic Related Group (s) (MS-DRG v40.0): 606 Minor skin disorders with mcc 607 Minor skin disorders without mcc Convert D04.30 to ICD-9-CM Code History 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM) 2017 (effective 10/1/2016): No change In no event shall CMS be liable for direct, indirect, special, incidental, or consequential CMS has defined "not usually self-administered" according to how the Medicare population as a whole uses the drug, not how an individual patient or physician may choose to use a particular drug. recommending their use. You can use the Contents side panel to help navigate the various sections. The 2023 edition of ICD-10-CM C44.52 became effective on October 1, 2022. required field. Healthcare providers are granted even more latitude for use of telehealth services during the COVID19 public health emergency. This page displays your requested Article. C44.62- Squamous cell carcinoma of skin of upper limb, including shoulder complete information, CMS does not guarantee that there are no errors in the information displayed on this web site. apply equally to all claims. Applications are available at the American Dental Association web site. All documentation must be maintained in the patient's medical record and made available to the contractor upon request. No portion of the American Hospital Association (AHA) copyrighted materials contained within this publication may be The AMA does not directly or indirectly practice medicine or dispense medical services. There are different article types: Articles are often related to an LCD, and the relationship can be seen in the "Associated Documents" section of the Article or the LCD. You are leaving the CMS MCD and are being redirected to the CMS MCD Archive that contains outdated (No Longer In Effect) Local Coverage Determinations and Articles, You are leaving the CMS MCD and are being redirected to, Billing and Coding: Destruction of Malignant Skin Lesions, AMA CPT / ADA CDT / AHA NUBC Copyright Statement, Article - Billing and Coding: Destruction of Malignant Skin Lesions (A57638). Check out the dx block of D04.4. Code History. GOVERNMENT AND ITS EMPLOYEES ARE NOT LIABLE FOR ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION, PRODUCT, OR PROCESSES The codes for squamous cell carcinoma are under category C44 Other and unspecified malignant neoplasm of skin. Draft articles are articles written in support of a Proposed LCD. [/QUOTE] This email will be sent from you to the When billing for non-covered services, use the appropriate modifier. It is derived from cells within the epidermis that make keratin the horny protein that makes up skin, hair and nails. will not infringe on privately owned rights. Billing and Coding articles typically include CPT/HCPCS procedure codes, ICD-10-CM diagnosis codes, as well as Bill Type, Revenue, and CPT/HCPCS Modifier codes. This common malignancy is primarily seen in older adults and most frequently occurs on sun-exposed skin. N0: no regional lymph node metastasis. Use of CDT is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). You, your employees and agents are authorized to use CPT only as agreed upon with the AMA internally within your organization within the United States for the sole use by yourself, employees and agents. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. If the diagnostic term in the pathology report is not in the list below, be sure to consult your ICD-O manual. For example, there is no way in ICD to distinguish between an adenocarcinoma of the lung and a squamous cell carcinoma of the lung: both would be coded to C34.9. This Agreement will terminate upon notice if you violate its terms. All neoplasms are classified in this chapter, whether they are functionally active or not. Cutaneous squamous cell carcinoma (SCC) is a common type of keratinocyte cancer, or non- melanoma skin cancer. The Medicare program provides limited benefits for outpatient prescription drugs. apply equally to all claims. C44.22- Squamous cell carcinoma of skin of ear and external auricular canal that coverage is not influenced by Revenue Code and the article should be assumed to apply equally to all Revenue Codes. The views and/or positions - C44.02 (squamous cell carcinoma of skin of lip) - 173.02 (squamous cell carcinoma of skin The Table of Neoplasms should be used to identify the correct topography code. that coverage is not influenced by Bill Type and the article should be assumed to In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material. All neoplasms are classified in this chapter, whether they are functionally active or not. 7500 Security Boulevard, Baltimore, MD 21244. Very few histological types are identified in ICD. In a few cases, such as for malignant melanoma and certain . End Users do not act for or on behalf of the CMS. The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient. CPT codes, descriptions and other data only are copyright 2022 American Medical Association. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (, malignant neoplasm of skin of genital organs (, Primary malignant neoplasm of skin of left shoulder, Primary malignant neoplasm of skin of left upper limb. how would you code the excessive bleeding from SCC of the left side of nose and most of the left cheek? Breast codes for ICD-10-CM include sex along with laterality. Codes should be selected from the table. An ambiguous, but moderate to high suspicion lesion would be excised with moderate to wide surrounding grossly normal skin/soft tissue margins, as for a malignant lesion. Revenue Codes are equally subject to this coverage determination. The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 11640, 11641, 11642, 11643, 11644, and 11646. An official website of the United States government. These materials contain Current Dental Terminology (CDTTM), copyright© 2022 American Dental Association (ADA). Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, CMS has defined "not usually self-administered" according to how the Medicare population as a whole uses the drug, not how an individual patient or physician may choose to use a particular drug. When verrucous carcinoma forms on your feet, they manage it as a skin cancer. Articles often contain coding or other guidelines that are related to a Local Coverage Determination (LCD). The program covers drugs that are furnished "incident-to" a physician's service provided that the drugs are not "usually self-administered" by the patient. Key words: For purpose of this exclusion, "the term 'usually' means more than 50 percent of the time for all Medicare beneficiaries who use the drug. You can use your browser's Print function (Ctrl-P on a PC or Command-P on a Mac) to view a print preview and then select PDF as the output. An asterisk (*) indicates a Skin []. All neoplasms are classified in this chapter, whether they are functionally active or not. Stage 0: tis: carcinoma in situ; n0: no regional lymph node metastasis; m0: no distant metastasis. Per the 2020 ICD-10 guidelines, 'consistent with' should be treated as an uncertain diagnosis, wh [QUOTE="TThivierge, post: 478222, member: 216725"] Request a Demo 14 Day Free Trial Buy Now Official Long Descriptor 625 0 obj <>/Filter/FlateDecode/ID[<300BF5E799812D49BBFB4D9A3883AA65>]/Index[604 32]/Info 603 0 R/Length 104/Prev 172627/Root 605 0 R/Size 636/Type/XRef/W[1 3 1]>>stream The AMA is a third party beneficiary to this Agreement. Squamous cell carcinoma, skin of left breast; Squamous cell carcinoma, skin of right breast; ICD-10-CM C44.521 is grouped within Diagnostic Related Group(s) (MS-DRG v 40.0): 606 Minor skin disorders with mcc; 607 Minor skin disorders without mcc; Convert C44.521 to ICD-9-CM. icd 10 code for bone marrow edema right knee. The responsibility for the content of this file/product is with CMS and no endorsement by the AMA is intended or implied. OPSCC cases were defined using the following International Classification of Disease for Oncology (ICD-O-3) site codes: base of tongue (C01.9 . When billing for non-covered services, use the appropriate modifier. Organizations who contract with CMS acknowledge that they may have a commercial CDT license with the ADA, and that use of CDT codes as permitted herein for the administration of CMS programs does not extend to any other programs or services the organization may administer and royalties dues for the use of the CDT codes are governed by their commercial license. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Squamous cell carcinoma of skin of lip C44.09 . %%EOF used to report this service. Notice: It is not appropriate to bill Medicare for services that are not covered (as described by the entire LCD) as if they are covered. To submit a comment or question to CMS, please use the Feedback/Ask a Question link available at the bottom B5l2`4'l2_v n6M#~zx#d[mp1VXlu[1NWJu~@}Z~@R'h&\x$f$e" =ih9L|-U*|=LeXOs9"eY9j=IYRh{p "AYqn[sNxD!D>* Hqq0.DzXCX|P| VGi] kb$+%=IpzpTkk*. C and E treatment involves removing the surface of the skin cancer with a scraping instrument (curet) and then searing the base of the cancer with an electric needle. This First Coast Billing and Coding Article for Local Coverage Determination (LCD) L33818 Excision of Malignant Skin Lesions provides billing and coding guidance for frequency limitations as well as diagnosis limitations that support diagnosis to procedure code automated denials. Applicable FARS\DFARS Restrictions Apply to Government Use. ICD-10-CM Coding instruction note: Excludes familial polycythemia (C75.0), secondary polycythemia (D75.1) D46.- Myelodysplastic syndromes . About 90% of cases of head and neck cancer (cancer of the mouth, nasal cavity, nasopharynx, throat and associated structures) are due to SCC.. %PDF-1.5 % The Medicare program provides limited benefits for outpatient prescription drugs. Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. Please enable "JavaScript" and revisit this page or proceed with browsing CMS.gov with All neoplasms are classified in this chapter, whether they are functionally active or not. determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. Medicare contractors are required to develop and disseminate Articles. without the written consent of the AHA. The 2023 edition of ICD-10-CM D04.9 became effective on October 1, 2022. In accordance with CMS Ruling 95-1 (V), utilization of these services should be consistent with locally acceptable standards of practice. See page 66 in ICD-O-3. article does not apply to that Bill Type. End User Point and Click Amendment: Please visit the. Sign up to get the latest information about your choice of CMS topics in your inbox. The 5th character is the sex code, while the 6th character is the laterality code. The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 11620, 11621, 11622, 11623, 11624, and 11626. Earn CEUs and the respect of your peers. We did one shave biopsy and the path report came back as Inflamed AK with extremely focal areas of squamous cell carcinoma in situ. Contractors may specify Bill Types to help providers identify those Bill Types typically You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials. [LIST] by John Verhovshek, MA, CPC Bowen's disease: squamous cell carcinoma in situ Bowen's disease is a premalignant condition that clinically presents as an asymptomatic, scaly or crusted plaque on the skin. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. These abnormal cells may become cancer and spread into nearby normal tissue. Federal government websites often end in .gov or .mil. Histology of SCC Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. hb```@( f p,&}5y5LJ"%%%3th/ $84C@1(6H(\Fed 6#V3gYq (carcinoma in situ of skin), excludes basal and squamous cell in situ lesions D13.7 Benign neoplasm of endocrine pancreas Note: Effective 1/1/2021: Review this code to look for the following which were . Your MCD session is currently set to expire in 5 minutes due to inactivity. ICD-10-CM Codes that Support Medical Necessity, ICD-10-CM Codes that DO NOT Support Medical Necessity, L33813 - Destruction of Malignant Skin Lesions, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 0.5 CM OR LESS, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 0.6 TO 1.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 1.1 TO 2.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 2.1 TO 3.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 3.1 TO 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER OVER 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 0.5 CM OR LESS, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 0.6 TO 1.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 1.1 TO 2.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 2.1 TO 3.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 3.1 TO 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER OVER 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 0.5 CM OR LESS, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 0.6 TO 1.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 1.1 TO 2.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 2.1 TO 3.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 3.1 TO 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER OVER 4.0 CM, Malignant neoplasm of overlapping sites of palate, Malignant neoplasm of palate, unspecified, Malignant neoplasm of overlapping sites of unspecified parts of mouth, Malignant neoplasm of overlapping sites of other parts of mouth, Malignant melanoma of unspecified eyelid, including canthus, Malignant melanoma of right upper eyelid, including canthus, Malignant melanoma of right lower eyelid, including canthus, Malignant melanoma of left upper eyelid, including canthus, Malignant melanoma of left lower eyelid, including canthus, Malignant melanoma of unspecified ear and external auricular canal, Malignant melanoma of right ear and external auricular canal, Malignant melanoma of left ear and external auricular canal, Malignant melanoma of unspecified part of face, Malignant melanoma of other parts of face, Malignant melanoma of other part of trunk, Malignant melanoma of unspecified upper limb, including shoulder, Malignant melanoma of right upper limb, including shoulder, Malignant melanoma of left upper limb, including shoulder, Malignant melanoma of unspecified lower limb, including hip, Malignant melanoma of right lower limb, including hip, Malignant melanoma of left lower limb, including hip, Malignant melanoma of overlapping sites of skin, Merkel cell carcinoma of unspecified eyelid, including canthus, Merkel cell carcinoma of right upper eyelid, including canthus, Merkel cell carcinoma of right lower eyelid, including canthus, Merkel cell carcinoma of left upper eyelid, including canthus, Merkel cell carcinoma of left lower eyelid, including canthus, Merkel cell carcinoma of unspecified ear and external auricular canal, Merkel cell carcinoma of right ear and external auricular canal, Merkel cell carcinoma of left ear and external auricular canal, Merkel cell carcinoma of unspecified part of face, Merkel cell carcinoma of other parts of face, Merkel cell carcinoma of other part of trunk, Merkel cell carcinoma of unspecified upper limb, including shoulder, Merkel cell carcinoma of right upper limb, including shoulder, Merkel cell carcinoma of left upper limb, including shoulder, Merkel cell carcinoma of unspecified lower limb, including hip, Merkel cell carcinoma of right lower limb, including hip, Merkel cell carcinoma of left lower limb, including hip, Merkel cell carcinoma of overlapping sites, Other specified malignant neoplasm of skin of lip, Basal cell carcinoma of skin of right upper eyelid, including canthus, Basal cell carcinoma of skin of right lower eyelid, including canthus, Basal cell carcinoma of skin of left upper eyelid, including canthus, Basal cell carcinoma of skin of left lower eyelid, including canthus, Squamous cell carcinoma of skin of right upper eyelid, including canthus, Squamous cell carcinoma of skin of right lower eyelid, including canthus, Squamous cell carcinoma of skin of left upper eyelid, including canthus, Squamous cell carcinoma of skin of left lower eyelid, including canthus, Other specified malignant neoplasm of skin of right upper eyelid, including canthus, Other specified malignant neoplasm of skin of right lower eyelid, including canthus, Other specified malignant neoplasm of skin of left upper eyelid, including canthus, Other specified malignant neoplasm of skin of left lower eyelid, including canthus, Basal cell carcinoma of skin of right ear and external auricular canal, Basal cell carcinoma of skin of left ear and external auricular canal, Squamous cell carcinoma of skin of right ear and external auricular canal, Squamous cell carcinoma of skin of left ear and external auricular canal, Other specified malignant neoplasm of skin of right ear and external auricular canal, Other specified malignant neoplasm of skin of left ear and external auricular canal, Basal cell carcinoma of skin of other parts of face, Squamous cell carcinoma of skin of other parts of face, Other specified malignant neoplasm of skin of nose, Other specified malignant neoplasm of skin of other parts of face, Basal cell carcinoma of skin of scalp and neck, Squamous cell carcinoma of skin of scalp and neck, Other specified malignant neoplasm of skin of scalp and neck, Basal cell carcinoma of skin of other part of trunk, Squamous cell carcinoma of skin of breast, Squamous cell carcinoma of skin of other part of trunk, Other specified malignant neoplasm of anal skin, Other specified malignant neoplasm of skin of breast, Other specified malignant neoplasm of skin of other part of trunk, Basal cell carcinoma of skin of right upper limb, including shoulder, Basal cell carcinoma of skin of left upper limb, including shoulder, Squamous cell carcinoma of skin of right upper limb, including shoulder, Squamous cell carcinoma of skin of left upper limb, including shoulder, Other specified malignant neoplasm of skin of right upper limb, including shoulder, Other specified malignant neoplasm of skin of left upper limb, including shoulder, Basal cell carcinoma of skin of right lower limb, including hip, Basal cell carcinoma of skin of left lower limb, including hip, Squamous cell carcinoma of skin of right lower limb, including hip, Squamous cell carcinoma of skin of left lower limb, including hip, Other specified malignant neoplasm of skin of right lower limb, including hip, Other specified malignant neoplasm of skin of left lower limb, including hip, Basal cell carcinoma of overlapping sites of skin, Squamous cell carcinoma of overlapping sites of skin, Other specified malignant neoplasm of overlapping sites of skin, Malignant neoplasm of peripheral nerves of head, face and neck, Malignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder, Malignant neoplasm of peripheral nerves of right upper limb, including shoulder, Malignant neoplasm of peripheral nerves of left upper limb, including shoulder, Malignant neoplasm of peripheral nerves of unspecified lower limb, including hip, Malignant neoplasm of peripheral nerves of right lower limb, including hip, Malignant neoplasm of peripheral nerves of left lower limb, including hip, Malignant neoplasm of peripheral nerves of thorax, Malignant neoplasm of peripheral nerves of abdomen, Malignant neoplasm of peripheral nerves of pelvis, Malignant neoplasm of peripheral nerves of trunk, unspecified, Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system, Malignant neoplasm of connective and soft tissue of head, face and neck, Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder, Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder, Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder, Malignant neoplasm of connective and soft tissue of unspecified lower limb, including hip, Malignant neoplasm of connective and soft tissue of right lower limb, including hip, Malignant neoplasm of connective and soft tissue of left lower limb, including hip, Malignant neoplasm of connective and soft tissue of thorax, Malignant neoplasm of connective and soft tissue of abdomen, Malignant neoplasm of connective and soft tissue of pelvis, Malignant neoplasm of connective and soft tissue of trunk, unspecified, Malignant neoplasm of overlapping sites of connective and soft tissue, Malignant neoplasm of head, face and neck, Malignant neoplasm of unspecified upper limb, Malignant neoplasm of unspecified lower limb, Malignant neoplasm of other specified ill-defined sites, Melanoma in situ of unspecified eyelid, including canthus, Melanoma in situ of right upper eyelid, including canthus, Melanoma in situ of right lower eyelid, including canthus, Melanoma in situ of left upper eyelid, including canthus, Melanoma in situ of left lower eyelid, including canthus, Melanoma in situ of unspecified ear and external auricular canal, Melanoma in situ of right ear and external auricular canal, Melanoma in situ of left ear and external auricular canal, Melanoma in situ of unspecified part of face, Melanoma in situ of breast (skin) (soft tissue), Melanoma in situ of unspecified upper limb, including shoulder, Melanoma in situ of right upper limb, including shoulder, Melanoma in situ of left upper limb, including shoulder, Melanoma in situ of unspecified lower limb, including hip, Melanoma in situ of right lower limb, including hip, Melanoma in situ of left lower limb, including hip, Carcinoma in situ of skin of unspecified eyelid, including canthus, Carcinoma in situ of skin of right upper eyelid, including canthus, Carcinoma in situ of skin of right lower eyelid, including canthus, Carcinoma in situ of skin of left upper eyelid, including canthus, Carcinoma in situ of skin of left lower eyelid, including canthus, Carcinoma in situ of skin of unspecified ear and external auricular canal, Carcinoma in situ of skin of right ear and external auricular canal, Carcinoma in situ of skin of left ear and external auricular canal, Carcinoma in situ of skin of unspecified part of face, Carcinoma in situ of skin of other parts of face, Carcinoma in situ of skin of scalp and neck, Carcinoma in situ of skin of unspecified upper limb, including shoulder, Carcinoma in situ of skin of right upper limb, including shoulder, Carcinoma in situ of skin of left upper limb, including shoulder, Carcinoma in situ of skin of unspecified lower limb, including hip, Carcinoma in situ of skin of right lower limb, including hip, Carcinoma in situ of skin of left lower limb, including hip, Some older versions have been archived.